IN THE NEWS
News Articles
Mind Matters
Milwaukee Magazine - By Claire HananMarquette’s New Seed Fund Underscores Entrepreneurship Push
Xconomy - By Jeff BuchananPromentis Turns to Montana Researchers to Boost Neuro Drug Tech
Xconomy - By Jeff EngelPromentis Pharmaceuticals completes venture financing
BioCentury Week in ReviewPromentis Pharmaceuticals raises $2.9M
Milwaukee Business Journal - By Rich KirchenPromentis Pharmaceuticals raises $2.9 million in venture capital
Milwaukee Journal Sentinel - By Kathleen GallagherSen. Baldwin sees her first bill complementing state venture capital bill
Milwaukee Business Journal – By Jeff EngelPromentis receives grant to develop schizophrenia drugs
Milwaukee Journal Sentinel - By Kathleen GallagherPromentis Pharmaceuticals receives funding from Michael J. Fox Foundation
Milwaukee Journal Sentinel - By Kathleen GallagherPromentis raises nearly $2M for schizophrenia drug development
MedCity News - By Brandon GlennSearching for a cure for the brain’s darkest diseases
Marquette Magazine - By Nicole Sweeney Etter
The articles contained in this section of the website are written and published by persons not affiliated with Promentis, unless otherwise noted. The views expressed in these articles are those of the author(s) and do not reflect the views of Promentis. Additionally, the information contained in these articles may not be current. Promentis disavows any obligation to correct or update the information contained in these articles.